Barclays »

Allogene Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $594k 185k 3.21
2023-09-30 $2.5M 787k 3.17
2023-06-30 $3.3M 669k 4.97
2023-03-31 $2.5M 501k 4.94
2022-12-31 $2.7M 423k 6.29
2022-09-30 $3.4M 318k 10.80
2022-06-30 $350k 31k 11.41
2022-03-31 $951k 104k 9.11
2021-12-31 $1.5M 100k 14.92
2021-09-30 $1.1M 44k 25.69
2021-06-30 $2.5M 96k 26.09
2021-03-31 $4.6M 130k 35.29
2020-12-31 $1.6M 61k 25.26
2020-09-30 $3.0M 79k 37.72
2020-06-30 $3.8M 89k 42.82
2020-03-31 $1.2M 62k 19.43
2019-12-31 $1.2M 48k 25.97
2019-09-30 $870k 32k 27.28
2019-06-30 $671k 25k 26.83
2019-03-31 $868k 30k 28.92
2018-12-31 $27k 984 27.03